Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
09/2006
09/21/2006US20060210571 Engineering antibodies that bind irreversibly
09/21/2006US20060210567 Antibodies against pd-1 and uses therefor
09/21/2006US20060210559 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
09/21/2006US20060210558 Hematopoietic cell selectin ligand polypeptides and methods of use thereof
09/21/2006US20060210544 Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient
09/21/2006DE102006006808A1 Nanobiotechnologische Vorrichtung für Anatomiestrukturnachbildungen Nanobiotechnological apparatus for anatomy structure reproductions
09/21/2006DE102005012532A1 Tissue cells increasing method in culture container, comprises laminating a carrier layer with growth medium and connecting living human/animal cells to layer and depositing layer
09/21/2006DE102005011648A1 Verfahren zur Erhöhung der Pilzresistenz in transgenen Pflanzen durch wirtsinduzierte Unterdrückung der Genexpression in Pilzpathogenen A method for increasing the resistance to fungi in transgenic plants by host induced suppression of gene expression in fungal pathogens
09/21/2006CA2742202A1 Ifbm's to promote the specific attachment of target analytes to the surface of orthopedic implants
09/21/2006CA2734043A1 Skin equivalent culture
09/21/2006CA2601677A1 Gene disruptions, compositions and methods relating thereto
09/21/2006CA2601525A1 Polypeptides having antimicrobial activity and polynucleotides encoding same
09/21/2006CA2601499A1 Skin equivalent culture
09/21/2006CA2601089A1 Methods of islet isolation and transplantation
09/21/2006CA2600730A1 Influenza hemagglutinin and neuraminidase variants
09/21/2006CA2600705A1 Slow-maturing, determinate peas
09/21/2006CA2600690A1 Recombinant e-selectin made in insect cells
09/21/2006CA2600560A1 Method for producing plant forming nodules with high nitrogen-fixing activity
09/21/2006CA2600505A1 Anti-mesothelin antibodies
09/21/2006CA2599381A1 Corn event 3272 and methods for detection thereof
09/21/2006CA2581402A1 Novel activating agent of glucose uptake and a screening method therefor
09/21/2006CA2578908A1 Expression vectors for enhanced transient gene expression and mammalian cells expressing them
09/20/2006EP1702980A1 Corynebacterium glutamicum gene encoding Hpr of phosphoenolpyruvate:sugar phosphotransferase system
09/20/2006EP1702979A2 Improved keratinocyte culture and uses thereof
09/20/2006EP1702978A2 Dry powder cells and cell culture reagents and methods of production thereof
09/20/2006EP1702928A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/20/2006EP1702632A1 Hair growth method
09/20/2006EP1702620A1 Immunopotentiator and method of enhancing immunological activity with the same
09/20/2006EP1702518A1 Plants which synthesise a modified starch, process for the production thereof and modified starch
09/20/2006EP1702214A2 Methods of treating asthma
09/20/2006EP1702064A2 A biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan
09/20/2006EP1702062A2 Differentiation of stem cells for therapeutic use
09/20/2006EP1702061A1 A method for isolating a self-renewing, multipotent slow-cycling cell
09/20/2006EP1702058A2 Methods and devices for microencapsulation of cells
09/20/2006EP1702052A1 Cultured cell and method and apparatus for cell culture
09/20/2006EP1701916A2 Electronic trading data integration and protection system
09/20/2006EP1701772A2 Biomolecule partition motifs and uses thereof
09/20/2006EP1701730A2 Method and vaccine comprising copolymer 1 for treatment of psychiatric disorders
09/20/2006EP1701688A2 Methods and compositions for directing migration of neural progenitor cells
09/20/2006EP1585426A4 Cell-seeded extracellular matrix grafts
09/20/2006EP1551991A4 Functional cardiomyocytes from human embryonic stem cells
09/20/2006EP1549755A4 Spliceosome mediated rna trans-splicing in stem cells
09/20/2006EP1527341A4 Interfacial biomaterials
09/20/2006EP1438337B1 Crystals of cytochrome p450 2c9, structures thereof and their use
09/20/2006EP1432792B1 Histone deacetylase 9
09/20/2006EP1404815B1 Human cord blood derived unrestricted somatic stem cells (ussc)
09/20/2006EP1356025B1 Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing cancer using said protooncogene
09/20/2006EP1356022A4 Method and apparatus to grow and mechanically condition cell cultures
09/20/2006EP1337624B1 Cell constructs which can be obtained from mesenschymal stem cells and cells derivable therefrom and the use thereof
09/20/2006EP1303530B1 CLONING AND PRODUCING THE N. i Bst /i NBI NICKING ENDONUCLEASE AND RELATED METHODS FOR USING NICKING ENDONUCLEASES IN SINGLE-STRANDED DISPLACEMENT AMPLIFICATION
09/20/2006EP1280897B1 Regulation of nf-at interacting protein nip 45 variant
09/20/2006EP1246841B1 Transcription factors containing two potential dna binding motifs
09/20/2006EP1135459B1 Method for culturing microorganisms in prefilled flexible containers
09/20/2006EP0929569B1 Methods of alleviating neuropathic pain using prosaposin-derived peptides
09/20/2006EP0819250B1 Multiparameter cell separation using releasable colloidal magnetic particles
09/20/2006EP0774004B1 Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme
09/20/2006CN2817772Y Tissue engineering bone graft
09/20/2006CN1836040A Method of elevating transformation efficiency in plant by adding copper ion
09/20/2006CN1836034A Methods of producing neurons
09/20/2006CN1835976A Aglycosyl anti- CD154 (CD 40 ligand) antibodies and uses thereof
09/20/2006CN1835971A Improved secretion of neublastin
09/20/2006CN1835969A Mechanism of conditional regulation of hypoxia-inducible factor-1 by von Hippel-Lindau tumor suppressor protein
09/20/2006CN1835968A Compositions and methods for increasing bone mineralization
09/20/2006CN1834253A Prepn and application of epiderm or hair follicle stem cell from souce of human early embryo
09/20/2006CN1834235A Method of fast separating epithelial cell from human scalp hair follicle
09/20/2006CN1834234A Method of increasing electrical perforated transfection efficiency of nerve stem cell from musk water-soluble extract
09/20/2006CN1834233A Preservative fluid for exfoliative cell
09/20/2006CN1276254C Testing method for filtering experimental compound and reagent box
09/20/2006CN1276083C Altering gene expression with ssDNA produced in vivo
09/20/2006CN1276079C Recombination high molecular form mannose binding lectin (MBL), preparing method and application thereof
09/20/2006CN1276078C Method and device for layering and fixing amnion and removing cell by using amnion 3D matrix tissue engineering scaffold
09/20/2006CN1276073C Microorganism and production of carotinoid compounds thereby
09/19/2006US7109404 Selfing, backcrosses, hybrid production, and crosses to populations to produce hybrid seeds and plants with superior characteristics, such as herbicide resistance, insect resistance, modified fatty acid metabolism, modified carbohydrate metabolism, and resistance to bacterial, fungal or viral disease
09/19/2006US7109403 Inbred corn line PHADP
09/19/2006US7109398 Soybean cultivar 0491730
09/19/2006US7109394 Methods for modulating floral organ identity, modulating floral organ number, increasing of meristem size, and delaying flowering time
09/19/2006US7109391 Plant farnesyltransferases
09/19/2006US7109390 Modulating gene expression in crop plants and transforming crop plants that display low transformation efficiencies with existing transformation methods
09/19/2006US7109320 Nucleic acid molecules encoding human tumor necrosis factor α-specific antibodies
09/19/2006US7109317 Recombinant nucleic acid encoding a composite protein, including a CAB domain with a portion of calcineurin A and a portion of calcineurin B, forming a tripartite complex with an FKBP/CAB ligand and an FKBP domain; gene transcription or activation of an intracellular signal transduction pathway
09/19/2006US7109296 Used to identify modulators of the 5-HT3 serotonin receptor complex, and to reconstitute a more realistic physiological 5-HT3 receptor response in recombinant systems
09/19/2006US7109293 System for detecting protease
09/19/2006US7109183 Phosphohalohydrins, process for the production thereof and use thereof
09/19/2006US7109167 Tetrapeptide
09/19/2006US7109160 Peptides containing the motif IGD and their use as cell migration modulators
09/19/2006US7109033 Methods of identifying an agent that modulates the activity of a plant stress-regulated regulatory element, and methods of determining whether a plant has been exposed to a stress
09/19/2006US7109032 Fibroblast growth factor, leukemia inhibitory factor, stem cell factor, biotin, selenium and pantothenate; culturing; bone and cartilage transplants; side effect reduction
09/19/2006US7109031 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
09/19/2006US7109029 Adenoviral transcription of colony stimulating factor; gene expression inhibition; antitumor agents; antiproliferative agents; tissue engineering
09/19/2006US7109028 Methods of isolating hepatic progenitors
09/19/2006US7109027 Aβ-Peptide screening assay
09/19/2006US7109026 Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment
09/19/2006US7109021 Can be used for the treatment of diabetes or for delaying the onset of diabetes
09/19/2006US7109020 Leguminous bacterium having potentiated nitrogen fixation ability
09/19/2006US7109018 Transformant producing secondary metabolite modified with functional group and novel biosynthesis genes
09/19/2006US7109017 Antibodies having preferential binding to proteases; screening for enzyme inhibitors used in therapy of neurodegenerative diseases, such as Alzheimer's disease
09/19/2006US7109002 obtained by recombinant expression of DNA of human herpes virus type 8, and which may be used in diagnosis and treatment of human diseases such as kaposi sarcoma, Castleman's disease, multiple myeloma, kidney cell carcinoma, mesangial proliferative glomerulonephritis or B cell lymphoma
09/19/2006US7109001 COBRA gene and uses thereof
09/19/2006US7108991 Receptors whose endogenous ligand has not been identified (orphan)
09/19/2006US7108989 Therapy